Figure 1
Figure 1. Risk of MM in relation to prediagnostic circulating levels of total adiponectin, HMW adiponectin, and leptin in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Risk of MM in relation to prediagnostic circulating levels of total adiponectin, HMW adiponectin, and leptin in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal